LowrieE.G., LewN.L.. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities.Am J Kidney Dis1990; 15: 458–82.
2.
AvramM.M., GoldwasserP., ErroaM., FeinP.A.. Predictors of survival in continuous ambulatory peritoneal dialysis patients: the importance of prealbumin and other nutritional and metabolic markers.Am J Kidney Dis1994; 23: 91–8.
3.
StruijkD.G., KredietR.T., KoomenG.C.M., BoeschotenE.N., AriszL.. The effect of serum albumin at the start of continuous ambulatory peritoneal dialysis treatment on patient survival.Perit Dial Int1994; 14: 121–6.
4.
ChurchillD.N., TaylorW., KeshaviahP.R.. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes.J Am Soc Nephrol1996; 7: 198–207.
5.
BlakeP.G., FlowerdewC., BlakeR.N., OreopoulosD.G.. Serum albumin in patients on continuous ambulatory peritoneal dialysis. Predictors, and correlations with outcomes.J Am Soc Nephrol1993; 3: 1501–7.
6.
TeehanB.P., SchleiferC.R., BrownJ.. Adequacy of continuous ambulatory peritoneal dialysis: morbidity and mortality in chronic peritoneal dialysis.Am J Kidney Dis1994; 24: 990–1001.
7.
SchoenfeldP.Y.. Albumin is an unreliable marker of nutritional status.Semin Dial1992; 5: 218–23.
8.
BallmerP.E., McNurlarM.A., GrantI., GarlickP.J.. Down-regulation of albumin synthesis in the rat by human recombinant interleukin-1beta or turpentine and the response to nutrients.J Parent Ent Nutr1995; 19: 266–71.
9.
KangD.H., YoonKl, LeeS.W.. Impact of nutritional status on serum lipoprotein (a) concentration in patients undergoing continuous ambulatory peritoneal dialysis.Perit Dial Int1996; 16: S241–5.
10.
BlumenkrantzM.J., GahlG.M., KoppleJ.D.. Protein losses during peritoneal dialysis.Kidney Int1981; 19: 593–602.
11.
KaysenG.A., SchoenfeldP.Y.. Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis.Kidney Int1984; 25: 107–14.
12.
NolphK.D., MooreH.L., ProwantB.. Continuous ambulatory peritoneal dialysis with a high flux membrane.ASAIO J1993; 39: 904–9.
13.
NolphK.D., MooreH.L., ProwantB.. Cross-sectional assessment of weekly urea and creatinine clearances and indices of nutrition in continuous ambulatory peritoneal dialysis patients.Perit Dial Int1993; 13: 178–83.
14.
BanisterW.F., AcchiardoS.R., MooreL.W., KrausA.P.. Nutritional effects of peritonitis in continuous ambulatory peritoneal dialysis (CAPD) patients.J Am Diet Assoc1987; 87: 53–6.
15.
FoxL., TzamaloukasA.H., MurataG.H.. Metabolic differences between persistent and routine peritonitis in continuous ambulatory peritoneal dialysis.Adv Perit Dial1992; 8: 346–50.
16.
MurataG.H., TzamaloukasA.H., MalhotraD.. Protein catabolic rate in patients on peritoneal dialysis: a multivariate predictive model.ASAIO J1996; 42: 46–51.
17.
HartyJ.C., BoultonH., KirwellJ.. The normalized protein catabolic rate is a flowed marker of nutrition in CAPD patients.Kidney Int1994; 45: 103–9.
18.
MalhotraD., TzamaloukasA.H., MurataG.H., FoxL., GoldmanR.S., AvasthiP.S.. Serum albumin in continuous peritoneal dialysis: its predictors and relationship to urea clearance.Kidney Int1996; 50: 243–9.
19.
BergstromJ., FurstP., AlverstrandA., LindholmB.. Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis.Kidney Int1993; 44: 1048–57.
20.
BergstromJ.. Appetite in CAPD patients.Perit Dial Int1996; 16: S181–4.
21.
JonesM.R.. Intraperitoneal amino acids: a therapy whose time has come?Perit Dial Int1995; 15: S67–74.
22.
RubinJ.. Nutritional support during peritoneal dialysis-related peritonitis.Am J Kidney Dis1990; 15: 551–5.
23.
FurstP.. New strategies in clinical nutrition.Perit Dial Int1996; 16: S28–35.
24.
NakayamaM., KuboO., OgawaA.. Immunohistochemical detection of advanced glycation end products in the peritoneum and its possible pathophysiological role in CAPD (Abstract).Perit Dial Int1996; 16(suppl): S95.
